Login   |   Register
Cover Image


Anti-thromboxane B2 antibodies protect against acetaminophen-induced liver injury in mice

Authors
Ivan Ćavar, Tomislav Kelava, Danijel Pravdić, Filip Čulo

Authors information
  • Ivan Ćavar
    Department of Physiology, Faculty of Medicine, University of Mostar, Bosnia and Herzegovina. ivancavarsb@yahoo.com
  • Tomislav Kelava
    Department of Physiology, Faculty of Medicine, University of Zagreb, Croatia.
  • Danijel Pravdić
    Department of Physiology, Faculty of Medicine, University of Mostar, Bosnia and Herzegovina.
  • Filip Čulo
    Department of Physiology, Faculty of Medicine, University of Mostar, Bosnia and Herzegovina; Department of Physiology, Faculty of Medicine, University of Zagreb, Croatia, Bosnia and Herzegovina.

Abstract


Prostanoids are lipid compounds that mediate a variety of physiological and pathological functions in almost all body tissues and organs. Thromboxane (TX) A2 is a powerful inducer of platelet aggregation and vasoconstriction and it has ulcerogenic activity in the gastrointestinal tract. Overdose or chronic use of a high dose of acetaminophen (N-acetyl-paminophenol, APAP) is a major cause of acute liver failure in the Western world. We investigated whether TXA2 plays a role in host response to toxic effect of APAP. CBA/H Zg mice of both sexes were intoxicated with a single lethal or high sublethal dose of APAP, which was administered to animals by oral gavage. The toxicity of APAP was determined by observing the survival of mice during 48 h, by measuring concentration of alanine-aminotransferase (ALT) in plasma 20-22 h after APAP administration and by liver histology. The results have shown that anti-thromboxane (TX) B2 antibodies (anti-TXB2) and a selective inhibitor of thromboxane (TX) synthase, benzylimidazole (BZI), were significantly hepatoprotective, while a selective thromboxane receptor (TPR) antagonist, daltroban, was slightly protective in this model of acute liver injury. A stabile metabolite of TXA2, TXB2, and a stabile agonist of TPR, U-46619, had no influence on APAP-induced liver damage. Our findings suggest that TXA2 has a pathogenic role in acute liver toxicity induced with APAP, which was highly abrogated by administration of anti-TXB2. According to our results, this protection is mediated, at least in part, through decreased production of TXB2 by liver fragments ex vivo.

Keywords


thromboxane A2, anti-TXB2 antibodies, acetaminophen, liver.

Full Text





Submitted: 2011-07-26 23:38:55
Published: 2011-12-21 17:46:26
Search for citations in Google Scholar
Related articles: Google Scholar

References



Article Metrics

Metrics Loading ...

Metrics powered by PLOS ALM


 

 

The Journal of Xenobiotics [eISSN 2039-4713] is a new Open Access, online-only, peer-reviewed journal published by PAGEPress®, Pavia, Italy. All credits and honors to PKP for their OJS.
 
© PAGEPress 2008-2015     -     PAGEPress is a registered trademark property of PAGEPress srl, Italy.     -     VAT: IT02125780185